Expert Interview
Evaluating Orforglipron’s Phase 3 ATTAIN-1 Results in Obesity Management
Ticker(s): LLY- Board Certified Endocrinologist fellowship trained at University of California San Francisco.
- Manages ~400 patients annually for weight loss and obesity.
- Practicing in endocrinology for over 20 years.
What is your impression of the ATTAIN-1 topline results for orforglipron compared to currently available GLP-1 receptor agonists?
Added By: sara_adminHow significant is the availability of an oral GLP-1 RA for your obesity or overweight patients without diabetes?
Added By: sara_adminWhat additional safety or efficacy data would you like to see from Eli Lilly before considering orforglipron in your clinical practice?
Added By: sara_adminWhat additional factors beyond BMI and comorbidities could guide future patient segmentation in obesity and diabetes? How do you think Lilly will focus its strategy on patient segmentation given its current portfolio (both current commercially available and in development)?
Added By: pharmaadvisorGiven the rapid advances in obesity management across multiple manufacturers, how do you see patient segmentation and treatment algorithms evolving over the next 2–3 years, and what impact will this have on real-world prescribing decisions and care pathways
Added By: pharmaadvisorAre You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Aug 19, 2025
- Call Time
- 05:00 PM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
